CSIMarket


Terms Beginning with H
                       
                       
 Haircut   Hemodialysis   HUD  
 Hazard Ratio HR   Hemofiltration Hemofiltrate   Hydrate  
 HDL Cholesterol   Hepatitis   Hydrometallurgical  
 Headcount-Related Expense   HFRX Indexes   Hypercholesterolemia  
 Heating degree days   High Grade Ore   Hyperlipoproteinemia  
 Heavy Crude Oil    HIV     
 Hedge   HMO Health maintenance organization     
 Hedge Fund-Linked Derivatives   Homocysteine     
 Hedging   Hourly Compensation     
 Hematopoietic Stem Cells   Hours Worked     
                 
                   
 
 
       
       
 

Hyperlipoproteinemia

Health Care Term


1. Type I (familial lipoprotein lipase deficiency): This is a rare genetic disorder that results in the buildup of chylomicrons in the blood, leading to pancreatitis and abdominal pain.

2. Type IIa (familial hypercholesterolemia): This is a genetic disorder that results in high levels of LDL cholesterol in the blood, increasing the risk of heart disease and stroke.

3. Type IIb (combined hyperlipidemia): This is a condition characterized by high levels of both LDL cholesterol and triglycerides in the blood.

4. Type III (familial dysbetalipoproteinemia): This results in high levels of remnant lipoproteins, which can lead to atherosclerosis and heart disease.

5. Type IV (familial hypertriglyceridemia): This is a condition characterized by high levels of triglycerides in the blood, which can lead to pancreatitis and cardiovascular disease.

Hyperlipoproteinemia is diagnosed through blood tests that measure the levels of lipoproteins in a patient's blood. Treatment options may include lifestyle changes such as diet and exercise, medications such as statins or fibrates, and in severe cases, plasmapheresis or lipoprotein apheresis.

Hyperlipoproteinemia is a significant concern for the health care industry, as it can lead to serious health outcomes and increased healthcare costs. Health care professionals play a critical role in managing hyperlipoproteinemia, through the diagnosis, treatment, and ongoing monitoring of patients with this condition. The development of new treatments and technologies in the health care industry, including the use of genetic testing and personalized medicine, may offer new opportunities to improve the management of hyperlipoproteinemia and other lipid-related disorders.


   
     

Hyperlipoproteinemia

Health Care Term


1. Type I (familial lipoprotein lipase deficiency): This is a rare genetic disorder that results in the buildup of chylomicrons in the blood, leading to pancreatitis and abdominal pain.

2. Type IIa (familial hypercholesterolemia): This is a genetic disorder that results in high levels of LDL cholesterol in the blood, increasing the risk of heart disease and stroke.

3. Type IIb (combined hyperlipidemia): This is a condition characterized by high levels of both LDL cholesterol and triglycerides in the blood.

4. Type III (familial dysbetalipoproteinemia): This results in high levels of remnant lipoproteins, which can lead to atherosclerosis and heart disease.

5. Type IV (familial hypertriglyceridemia): This is a condition characterized by high levels of triglycerides in the blood, which can lead to pancreatitis and cardiovascular disease.

Hyperlipoproteinemia is diagnosed through blood tests that measure the levels of lipoproteins in a patient's blood. Treatment options may include lifestyle changes such as diet and exercise, medications such as statins or fibrates, and in severe cases, plasmapheresis or lipoprotein apheresis.

Hyperlipoproteinemia is a significant concern for the health care industry, as it can lead to serious health outcomes and increased healthcare costs. Health care professionals play a critical role in managing hyperlipoproteinemia, through the diagnosis, treatment, and ongoing monitoring of patients with this condition. The development of new treatments and technologies in the health care industry, including the use of genetic testing and personalized medicine, may offer new opportunities to improve the management of hyperlipoproteinemia and other lipid-related disorders.


Related Health Care Terms
                     
                     
 Adenocarcinoma   Analogues   Arrhythmia  
 Adenosine   ANDA Abbreviated New Drug Application   Arteriosclerosis  
 Adult Stem Cell   Angina   Atherosclerosis  
 Adverse Event   Angiogenesis   Autologous  
 Agonist   Angioplasty   Balloon Angioplasty  
 AIDS   Antagonist   Bioavailability  
 Alkylation Agent   Anti Hypertensive   Biologic Products  
 Allogeneic   Antibody   Biomarker  
 Amino Acid   Antigen   Bradycardia  
 Analgesic   API   Cancer  
               
                  next arrow
 
   


Help

About us

Advertise